Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Ceresoli, Gl; Zucali, Pa; Mencoboni, M; Botta, M; Grossi, F; Cortinovis, D; Zilembo N, ; Ripa, C; Tiseo, M; Favaretto, Ag; Soto-Parra, H; De Vincenzo, F; Bruzzone, A; Lorenzi, E; Gianoncelli, L; Ercoli, B; Giordano, L; Santoro, A